BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7762407)

  • 21. Albumin, bradykinins, and eosinophil cationic protein on the nasal mucosal surface in patients with hay fever during natural allergen exposure.
    Svensson C; Andersson M; Persson CG; Venge P; Alkner U; Pipkorn U
    J Allergy Clin Immunol; 1990 May; 85(5):828-33. PubMed ID: 2332562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nasal response to allergen challenge in patients with immediate asthmatic reaction.
    Palczynski C; Krakowiak A; Ruta U; Krajewska B; Rudzinski J; Gielec L; Górski P
    Allergol Immunopathol (Madr); 1996; 24(4):163-8. PubMed ID: 8939272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of Japanese cedar pollen-specific IgE in nasal secretions.
    Sakaida H; Masuda S; Takeuchi K
    Allergol Int; 2014 Sep; 63(3):467-73. PubMed ID: 24957114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allergen-induced eosinophil cytolysis is a primary mechanism for granule protein release in human upper airways.
    Erjefält JS; Greiff L; Andersson M; Matsson E; Petersen H; Linden M; Ansari T; Jeffery PK; Persson CG
    Am J Respir Crit Care Med; 1999 Jul; 160(1):304-12. PubMed ID: 10390416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated levels of interleukin-33 in the nasal secretions of patients with allergic rhinitis.
    Asaka D; Yoshikawa M; Nakayama T; Yoshimura T; Moriyama H; Otori N
    Int Arch Allergy Immunol; 2012; 158 Suppl 1():47-50. PubMed ID: 22627366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eosinophilic cationic protein as a marker of nasal inflammation in patients with cystic fibrosis.
    Weber A; Kiefer J; Peters S; Schneider M; Bargon J; May A
    Laryngoscope; 1999 Oct; 109(10):1696-702. PubMed ID: 10522945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of anti-immunoglobulin E on nasal inflammation in patients with seasonal allergic rhinoconjunctivitis.
    Bez C; Schubert R; Kopp M; Ersfeld Y; Rosewich M; Kuehr J; Kamin W; Berg AV; Wahu U; Zielen S
    Clin Exp Allergy; 2004 Jul; 34(7):1079-85. PubMed ID: 15248853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of recombinant human interleukin-5 on eosinophil accumulation and degranulation in human nasal mucosa.
    Terada N; Konno A; Tada H; Shirotori K; Ishikawa K; Togawa K
    J Allergy Clin Immunol; 1992 Aug; 90(2):160-8. PubMed ID: 1500623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Topical eosinophil responses after allergen challenge in patients with nasal allergy].
    Narita S; Saito H; Asakura K; Shirasaki H; Kataura A
    Nihon Jibiinkoka Gakkai Kaiho; 1994 Jun; 97(6):1062-9. PubMed ID: 8051595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cluster epithelial cells in nasal secretions of allergic rhinitis and its relation to eosinophils].
    Yang P; Fan D; Zhang T
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1996; 31(3):159-61. PubMed ID: 9639715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Norm values for eosinophil cationic protein in nasal secretions: influence of specimen collection.
    Klimek L; Rasp G
    Clin Exp Allergy; 1999 Mar; 29(3):367-74. PubMed ID: 10202345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum levels of eosinophil cationic protein and eosinophil protein x in pollen atopic patients with stable asthma and its relation with bronchial hyperresponsiveness.
    Chivato T; Martínez D; Blasco R; Melgarejo M; Gómez de Terreros FJ; Laguna R
    Allergol Immunopathol (Madr); 1996; 24(6):243-7. PubMed ID: 9010559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Eosinophil cationic protein as a marker of eosinophil activity].
    Czerwionka-Szaflarska M; Gasiorowska J
    Przegl Lek; 2006; 63(7):579-82. PubMed ID: 17203813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Levels of interleukin-4, interleukin-5, tryptase and eosinophil cationic protein of nasal lavage fluid in pollen allergic rhinitis].
    Rapp J; Kósa L; Halász A; Kereki E; Börzsönyi L
    Orv Hetil; 2000 Aug; 141(35):1919-22. PubMed ID: 11019593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Reration between symptom and counts of scattering Japanese cedar pollen--examination of clinical observation and repeated provocation].
    Yoshida H; Shimizu H; Fukami S
    Arerugi; 1996 Jan; 45(1):49-61. PubMed ID: 8851316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnostic value of selected eosinophil activity parameters in children with hay fever].
    Cichocka-Jarosz E; Lis G; Pietrzyk JJ
    Przegl Lek; 1997; 54(9):607-13. PubMed ID: 9501680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The distribution of eosinophil cationic protein positive eosinophils in the nasal mucosa of the nasal allergy patients.
    Naito K; Takeda N; Yokoyama N; Ibata K; Ishihara M; Senoh Y; Iwata S
    Auris Nasus Larynx; 1993; 20(3):197-204. PubMed ID: 8297267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epithelial cells in nasal fluids from patients with allergic rhinitis: how do they relate to epidermal growth factor, eosinophils and eosinophil cationic protein?
    Benson M; Uddman R; Cardell LO
    Acta Otolaryngol; 2002 Mar; 122(2):202-5. PubMed ID: 11936914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Noninvasive biological evaluation of response to pranlukast treatment in pediatric patients with Japanese cedar pollinosis.
    Gotoh M; Okubo K; Hashiguchi K; Wakabayashi K; Kanzaki S; Tanaka N; Fujioka M; Kawashima K; Suematsu K; Sasaki K; Iwasaki M; Yamamotoya H
    Allergy Asthma Proc; 2012; 33(6):459-66. PubMed ID: 23394502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repeatability and validity of cell and fluid-phase measurements in nasal fluid: a comparison of two methods of nasal lavage.
    Belda J; Parameswaran K; Keith PK; Hargreave FE
    Clin Exp Allergy; 2001 Jul; 31(7):1111-5. PubMed ID: 11468003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.